(Q36999855)

17 August 2017

CSF biomarker variability in the Alzheimer's Association quality control program (English)

1 reference

10.1016/J.JALZ.2014.12.004

17 August 2017

0 references

0 references

0 references

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1016/J.JALZ.2014.12.004

Steven Collins

5

0 references

Marcel Verbeek

Marcel M Verbeek

30

0 references

Piero Parchi

Piero Parchi

19

0 references

José Luis Molinuevo

José L Molinuevo

18

0 references

Henrik Zetterberg

31

Henrik Zetterberg

1 reference

17 August 2017

32

Kaj Blennow

1 reference

17 August 2017

27

John Q Trojanowski

1 reference

17 August 2017

4

Maria C Carrillo

1 reference

17 August 2017

26

Charlotte E Teunissen

1 reference

17 August 2017

9

Anne M Fagan

1 reference

17 August 2017

12

Bradley Hyman

1 reference

17 August 2017

1

Niklas Mattsson

1 reference

17 August 2017

2

Ulf Andreasson

1 reference

17 August 2017

25

Leslie M Shaw

1 reference

17 August 2017

28

Hugo Vanderstichele

1 reference

17 August 2017

29

Manu Vandijck

1 reference

17 August 2017

21

Robert A Rissman

1 reference

17 August 2017

17

Piotr Lewczuk

1 reference

17 August 2017

Staffan Persson

3

1 reference

17 August 2017

Sonia Chalbot

6

1 reference

17 August 2017

Neal Cutler

7

1 reference

17 August 2017

Diane Dufour-Rainfray

8

1 reference

17 August 2017

Niels H H Heegaard

10

1 reference

17 August 2017

Ging-Yuek Robin Hsiung

11

1 reference

17 August 2017

Khalid Iqbal

13

1 reference

17 August 2017

Stephan A Kaeser

14

1 reference

17 August 2017

D Richard Lachno

15

1 reference

17 August 2017

Alberto Lleó

16

1 reference

17 August 2017

Axel Regeniter

20

1 reference

17 August 2017

Hanna Rosenmann

22

1 reference

17 August 2017

Giuseppe Sancesario

23

1 reference

17 August 2017

Johannes Schröder

24

1 reference

17 August 2017

Alzheimer's Association QC Program Work Group

33

1 reference

17 August 2017

language of work or name

1 reference

1 May 2013

1 reference

17 August 2017

Alzheimer's and Dementia

1 reference

17 August 2017

9

1 reference

17 August 2017

3

1 reference

17 August 2017

251-261

1 reference

Neurochemical dementia diagnostics for Alzheimer's disease and other dementias: an ISO 15189 perspective

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Analytical aspects of molecular Alzheimer's disease biomarkers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden--regulatory considerations by European Medicines Agency focusing in improving be

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

What is a certified reference material?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Revising the definition of Alzheimer's disease: a new lexicon.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

International quality control survey of neurochemical dementia diagnostics.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

Preanalytical Sample Handling and Sample Stability Testing for the Neurochemical Dementia Diagnostics

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707386

10.1016/J.JALZ.2013.01.010

4 December 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23622690

1 reference